• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为一种新型癌症疗法的细胞凋亡吞噬作用调控。

Regulation of efferocytosis as a novel cancer therapy.

机构信息

Department of Surgical Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

出版信息

Cell Commun Signal. 2020 May 5;18(1):71. doi: 10.1186/s12964-020-00542-9.

DOI:10.1186/s12964-020-00542-9
PMID:32370748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7199874/
Abstract

Efferocytosis is a physiologic phagocytic clearance of apoptotic cells, which modulates inflammatory responses and the immune environment and subsequently facilitates immune escape of cancer cells, thus promoting tumor development and progression. Efferocytosis is an equilibrium formed by perfect coordination among "find-me", "eat-me" and "don't-eat-me" signals. These signaling pathways not only affect the proliferation, invasion, metastasis, and angiogenesis of tumor cells but also regulate adaptive responses and drug resistance to antitumor therapies. Therefore, efferocytosis-related molecules and pathways are potential targets for antitumor therapy. Besides, supplementing conventional chemotherapy, radiotherapy and other immunotherapies with efferocytosis-targeted therapy could enhance the therapeutic efficacy, reduce off-target toxicity, and promote patient outcome. Video abstract.

摘要

吞噬作用是一种生理性的吞噬清除凋亡细胞的过程,它调节炎症反应和免疫环境,从而促进癌细胞的免疫逃逸,进而促进肿瘤的发展和进展。吞噬作用是由“找我”、“吃我”和“别吃我”信号之间的完美协调形成的平衡。这些信号通路不仅影响肿瘤细胞的增殖、侵袭、转移和血管生成,还调节抗肿瘤治疗的适应性反应和耐药性。因此,吞噬作用相关的分子和途径是抗肿瘤治疗的潜在靶点。此外,将吞噬作用靶向治疗与传统的化疗、放疗和其他免疫疗法相结合,可以增强治疗效果,降低脱靶毒性,改善患者的预后。视频摘要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd25/7201599/6eb2ce71e876/12964_2020_542_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd25/7201599/6eb2ce71e876/12964_2020_542_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd25/7201599/6eb2ce71e876/12964_2020_542_Fig1_HTML.jpg

相似文献

1
Regulation of efferocytosis as a novel cancer therapy.作为一种新型癌症疗法的细胞凋亡吞噬作用调控。
Cell Commun Signal. 2020 May 5;18(1):71. doi: 10.1186/s12964-020-00542-9.
2
Efferocytosis and the Story of "Find Me," "Eat Me," and "Don't Eat Me" Signaling in the Tumor Microenvironment.肿瘤微环境中的吞噬作用和“找我”、“吃我”和“别吃我”信号转导的故事。
Adv Exp Med Biol. 2021;1329:153-162. doi: 10.1007/978-3-030-73119-9_8.
3
Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms.动脉粥样硬化病变中的噬斑细胞清除作用:功能失调的调节途径和控制机制。
Pharmacol Ther. 2018 Aug;188:12-25. doi: 10.1016/j.pharmthera.2018.02.003. Epub 2018 Feb 11.
4
"Find Me" and "Eat Me" signals: tools to drive phagocytic processes for modulating antitumor immunity.“找我”和“吃我”信号:用于调节抗肿瘤免疫的吞噬过程的工具。
Cancer Commun (Lond). 2024 Jul;44(7):791-832. doi: 10.1002/cac2.12579. Epub 2024 Jun 23.
5
Efferocytosis: molecular mechanisms and pathophysiological perspectives.吞噬作用:分子机制和病理生理学视角。
Immunol Cell Biol. 2019 Feb;97(2):124-133. doi: 10.1111/imcb.12206. Epub 2018 Oct 16.
6
The complex roles of efferocytosis in cancer development, metastasis, and treatment.吞噬作用在癌症发展、转移和治疗中的复杂作用。
Biomed Pharmacother. 2021 Aug;140:111776. doi: 10.1016/j.biopha.2021.111776. Epub 2021 May 29.
7
Putting the brakes on phagocytosis: "don't-eat-me" signaling in physiology and disease.抑制吞噬作用:生理学和疾病中的“别吃我”信号。
EMBO Rep. 2021 Jun 4;22(6):e52564. doi: 10.15252/embr.202152564. Epub 2021 May 27.
8
Assessment of the Immune Response to Tumor Cell Apoptosis and Efferocytosis.评估肿瘤细胞凋亡和吞噬作用的免疫反应。
Methods Mol Biol. 2022;2543:45-55. doi: 10.1007/978-1-0716-2553-8_5.
9
Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions.巨噬细胞衍生的神经纤毛蛋白-2 具有新的肿瘤促进功能。
Cancer Res. 2018 Oct 1;78(19):5600-5617. doi: 10.1158/0008-5472.CAN-18-0562. Epub 2018 Aug 15.
10
Efferocytosis: Unveiling its potential in autoimmune disease and treatment strategies.吞噬作用:揭示其在自身免疫性疾病和治疗策略中的潜力。
Autoimmun Rev. 2024 Jun;23(6):103578. doi: 10.1016/j.autrev.2024.103578. Epub 2024 Jul 14.

引用本文的文献

1
Development of a prognostic RiskScore model using efferocytosis-related signature genes for lung adenocarcinoma.使用与胞葬作用相关的特征基因开发肺腺癌预后风险评分模型。
PeerJ. 2025 Sep 5;13:e19892. doi: 10.7717/peerj.19892. eCollection 2025.
2
Engineered biomimetic vesicles induce cuproptosis and disrupt efferocytosis for metastatic adenoid cystic carcinoma immunotherapy.工程化仿生囊泡诱导铜死亡并破坏吞噬作用以用于转移性腺样囊性癌免疫治疗。
Mater Today Bio. 2025 Aug 23;34:102233. doi: 10.1016/j.mtbio.2025.102233. eCollection 2025 Oct.
3
Mapping the evolving trend of research on efferocytosis: a comprehensive data-mining-based study.

本文引用的文献

1
Immune Responses in Bladder Cancer-Role of Immune Cell Populations, Prognostic Factors and Therapeutic Implications.膀胱癌中的免疫反应——免疫细胞群体的作用、预后因素及治疗意义
Front Oncol. 2019 Nov 20;9:1270. doi: 10.3389/fonc.2019.01270. eCollection 2019.
2
AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications.AXL 受体酪氨酸激酶作为一种有前途的抗癌方法:功能、分子机制和临床应用。
Mol Cancer. 2019 Nov 4;18(1):153. doi: 10.1186/s12943-019-1090-3.
3
Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment.
绘制胞葬作用研究的演变趋势:一项基于全面数据挖掘的研究
BioData Min. 2025 Aug 25;18(1):58. doi: 10.1186/s13040-025-00475-4.
4
Efferocytosis in tissue engineering: A comprehensive review of emerging therapeutic strategies for enhanced tissue repair and regeneration.组织工程中的胞葬作用:增强组织修复与再生的新兴治疗策略综述
Bioact Mater. 2025 Jun 9;52:155-181. doi: 10.1016/j.bioactmat.2025.05.026. eCollection 2025 Oct.
5
ALOX15B-based efferocytosis clusters: prognostic implications and immune cell infiltration in breast cancer.基于ALOX15B的胞葬作用簇:乳腺癌中的预后意义及免疫细胞浸润
Discov Oncol. 2025 Jun 19;16(1):1159. doi: 10.1007/s12672-025-02961-x.
6
Dys-regulated phosphatidylserine externalization as a cell intrinsic immune escape mechanism in cancer.磷脂酰丝氨酸外化失调作为癌症中一种细胞内在免疫逃逸机制
Cell Commun Signal. 2025 Mar 11;23(1):131. doi: 10.1186/s12964-025-02090-6.
7
Cholesterol efflux protein, ABCA1, supports anti-cancer functions of myeloid immune cells.胆固醇流出蛋白ABCA1支持髓系免疫细胞的抗癌功能。
bioRxiv. 2025 Feb 19:2025.02.19.638515. doi: 10.1101/2025.02.19.638515.
8
Engineered macrophage nanoparticles enhance microwave ablation efficacy in osteosarcoma via targeting the CD47-SIRPα Axis: A novel Biomimetic immunotherapeutic approach.工程化巨噬细胞纳米颗粒通过靶向CD47-SIRPα轴增强骨肉瘤的微波消融疗效:一种新型仿生免疫治疗方法。
Bioact Mater. 2025 Jan 24;47:248-265. doi: 10.1016/j.bioactmat.2025.01.012. eCollection 2025 May.
9
Efferocytosis-related gene IL33 predicts prognosis and immune response and mediates proliferation and migration and of breast cancer.与胞葬作用相关的基因IL33可预测乳腺癌的预后和免疫反应,并介导其增殖和迁移。
Front Pharmacol. 2025 Jan 22;16:1533571. doi: 10.3389/fphar.2025.1533571. eCollection 2025.
10
Clinical significance of lipid pathway-targeted therapy in breast cancer.脂质途径靶向治疗在乳腺癌中的临床意义。
Front Pharmacol. 2025 Jan 6;15:1514811. doi: 10.3389/fphar.2024.1514811. eCollection 2024.
靶向 TAM 受体(TYRO3、AXL 和 MERTK):肿瘤微环境中巨噬细胞的作用。
Mol Cancer. 2019 May 14;18(1):94. doi: 10.1186/s12943-019-1022-2.
4
A novel human anti-AXL monoclonal antibody attenuates tumour cell migration.一种新型人源抗 AXL 单克隆抗体可减弱肿瘤细胞迁移。
Scand J Immunol. 2019 Aug;90(2):e12777. doi: 10.1111/sji.12777. Epub 2019 Jun 7.
5
Axl is a novel target of celastrol that inhibits cell proliferation and migration, and increases the cytotoxicity of gefitinib in EGFR mutant non‑small cell lung cancer cells.阿克塞尔是一种新型的雷公藤红素靶标,可抑制细胞增殖和迁移,并增加表皮生长因子受体突变型非小细胞肺癌细胞中西地那非的细胞毒性。
Mol Med Rep. 2019 Apr;19(4):3230-3236. doi: 10.3892/mmr.2019.9957. Epub 2019 Feb 14.
6
Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl.双氢青蒿素通过JARID2/miR-7/miR-34a依赖的Axl下调抑制前列腺癌。
Oncogenesis. 2019 Feb 19;8(3):14. doi: 10.1038/s41389-019-0122-6.
7
MFG-E8 overexpression is associated with poor prognosis in breast cancer patients.在乳腺癌患者中,乳脂肪球表皮生长因子8(MFG-E8)过表达与预后不良相关。
Pathol Res Pract. 2019 Mar;215(3):490-498. doi: 10.1016/j.prp.2018.12.036. Epub 2018 Dec 31.
8
Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1.治疗诱导的肿瘤细胞凋亡和继发性坏死通过 MerTK 和 IDO1 在残留肿瘤微环境中驱动肿瘤进展。
Cancer Res. 2019 Jan 1;79(1):171-182. doi: 10.1158/0008-5472.CAN-18-1106. Epub 2018 Nov 9.
9
Efferocytosis: molecular mechanisms and pathophysiological perspectives.吞噬作用:分子机制和病理生理学视角。
Immunol Cell Biol. 2019 Feb;97(2):124-133. doi: 10.1111/imcb.12206. Epub 2018 Oct 16.
10
MERTK Promotes Resistance to Irreversible EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancers Expressing Wild-type Family Members.MERTK 促进表达野生型家族成员的非小细胞肺癌对不可逆 EGFR 酪氨酸激酶抑制剂的耐药性。
Clin Cancer Res. 2018 Dec 15;24(24):6523-6535. doi: 10.1158/1078-0432.CCR-18-0040. Epub 2018 Sep 7.